U.S. Department of Health and Human Services
Staff Search  

If you plan to apply, Register Early.

Registration is required at eRA Commons and grants.gov and can take 4 weeks.​

Diabetes and Metabolism HIV/AIDS

The Diabetes and Metabolism HIV/AIDS program supports studies on the metabolic complications of HIV infection, which encompass research on the endocrine and body composition abnormalities associated with HIV infection and its treatment.  Specific areas of support include studies of:  (1) hormones and cytokines involved in wasting syndromes; (2) changes in body composition in HIV patients; and (3) abnormalities of insulin sensitivity--and other components of the "Metabolic Syndrome" or "Syndrome X"--in patients with HIV.​​​​​​​​​​​​​​​​​​​

​​​​​​​​​
 

 NIDDK Staff

 
Saul Malozowski, M.D., Ph.D., M.B.A.Neuroendocrinology of hypothalamic-pituitary axis, neuropeptide signaling and receptors; hormonal regulation of bone and mineral metabolism

 

 Related Funding Opportunities

 
Posted DateTitleFull Announcement
3/21/2014Limited Competition: Continuation of the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study (U01) (Summary) RFA-DK-14-502
3/12/2014Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) (U01) (Summary) RFA-DK-14-501
3/7/2014Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) (Summary) PA-14-147
3/7/2014Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31 - Diversity) (Summary) PA-14-148
3/7/2014Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) (Summary) PA-14-149
View More Funding Opportunities

 

 Research Resources

 
Resource NameDescription
NIDDK Information Network

The NIDDK Information Network (dkNET), serves the needs of basic and clinical investigators by providing seamless access to large pools of data relevant to the mission of NIDDK. The goal of … (Summary)

Sirt3 KO (Sirt3 tm1.1Cxd) Mouse

Sirt3 KO: Sirt3 is a mitochondrial-localized tumor suppressor that maintains mitochondrial integrity and metabolism during stress.

 

SirT3 is a mitochondrial protein that is … (Summary)

Sirt1 KO (Sirt1 tm1.1Cxd) Mouse

Sirt1 knockout: Sirt1, a protein deacetylase, is a tumor suppressor that promotes genome stability and regulates proteins involved in energy metabolism.

 

Yeast Sir2, a nicotinamide … (Summary)

M3 Muscarinic Receptor Knockout mice are hypophagic, lean, and have improved glucose tolerance and insulin sensitivity.

M3 Muscarinic Receptor Knockout mice are hypophagic, lean, and have improved glucose tolerance and insulin sensitivity.

 

The five Muscarinic Acetylcholine (ACh) receptors … (Summary)

Gs Alpha LoxP (Gnas tm1Lsw) Mouse

Generation of a floxed Gnsa gene for the G-protein Gsα for the construction of conditional knockout mice.

 

The heterotrimeric G protein Gsa couples many receptors to adenylyl … (Summary)

View Additional Research Resources

 

 NIDDK Active Trials in HIV/AIDS

 
View related clinical trials from ClinicalTrials.gov​.

 

 Related Study Sections

 
​Study sections conduct initial peer review of applications in a designated scientific area. View related study sections from the NIH's Center for Scientific Review.​